Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
373,915
-
Shares change
-
+3,997
-
Total reported value, excl. options
-
$262,370
-
Value change
-
+$4,515
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$0.715
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q1 2023
10 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q1 2023.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 373,915 shares
of 2,850,581 outstanding shares and own 13.12% of the company stock.
Largest 10 shareholders include BRIDGEWAY CAPITAL MANAGEMENT, LLC (286,100 shares), Virtu Financial LLC (29,137 shares), TWO SIGMA SECURITIES, LLC (25,303 shares), GEODE CAPITAL MANAGEMENT, LLC (20,179 shares), ADVISOR GROUP HOLDINGS, INC. (6,628 shares), NATIONAL BANK OF CANADA /FI/ (6,042 shares), New England Capital Financial Advisors LLC (500 shares), Federation des caisses Desjardins du Quebec (79 shares), MORGAN STANLEY (26 shares), and BANK OF AMERICA CORP /DE/ (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.